Luminopia, INC.

Digital therapeutics company.

Based in MA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $0 in lobbying spend across 5 quarterly filings, Luminopia, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2024.

$0
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$0
2024$0

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

Bluebird Strategies

Lobbyists

John Brennan

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

  • •H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Akebia Therapeutics, INC.
$9.8M total spend
Ardelyx, INC.
$9.4M total spend
Sage Therapeutics
$4.8M total spend
Organogenesis INC.
$4.0M total spend
Lantheus Holdings, INC.
$3.9M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.